Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Heran Deng"'
Autor:
Yunfang Yu, Xueyuan Jia, Sunyu Chen, Zijia Lai, Heran Deng, Yuqian Mo, Xinxin Xie, Zehua Wang, Ruichong Lin, Wenhao Ouyang, Herui Yao, Jiannan Wu
Publikováno v:
Frontiers in Genetics, Vol 15 (2024)
Background: In breast cancer oncogenesis, the precise role of cell apoptosis holds untapped potential for prognostic and therapeutic insights. Thus, it is important to develop a model predicated for breast cancer patients’ prognosis and immunothera
Externí odkaz:
https://doaj.org/article/452a33a5753b47d6944d016c5ed7e286
Autor:
Heran Deng, Liying Wang, Na Wang, Kejin Zhang, Yanxia Zhao, Pengfei Qiu, Xiaowei Qi, Danhua Zhang, Fei Xu, Jieqiong Liu
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-9 (2023)
Abstract Purpose Despite the poor prognosis of triple-negative breast cancer (TNBC), it has been demonstrated that neoadjuvant immunotherapy in combination with chemotherapy can improve the pathologic complete response (pCR) rate and/or long-term out
Externí odkaz:
https://doaj.org/article/abfc9d39dad54207b3772449d7f9656b
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundWomen with atypical hyperplasia (AH) is associated with a higher risk of future breast cancer. However, whether AH found at margins in patients with breast-conserving surgery (BCS) after neoadjuvant chemotherapy (NAC) needs re-excision is n
Externí odkaz:
https://doaj.org/article/6ba1339348754434a2dc886dec37356d
Autor:
Wei Wu, Jiewen Chen, Heran Deng, Liang Jin, Zhanghai He, Nanyan Rao, Yan Nie, Yandan Yao, Yaping Yang, Fengxi Su, Jieqiong Liu
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-12 (2021)
Abstract Background Here we evaluated the feasibility, efficacy, tolerability, and treatment-mediated immune modulation of neoadjuvant everolimus plus letrozole versus chemotherapy in treating postmenopausal patients with ER-positive, HER2-negative b
Externí odkaz:
https://doaj.org/article/6177ffceb2014b5b9cae1e9c928e4cd6
Publikováno v:
BMC Surgery, Vol 20, Iss 1, Pp 1-4 (2020)
Abstract Background Paradoxical embolism (PDE) presented with concomitant pulmonary embolism (PE) and renal artery embolism (RAE) which occurred to breast cancer patient after breast-conserving therapy, has never been reported. Case presentation A 55
Externí odkaz:
https://doaj.org/article/add12001327147d1a76221c506042bee
Autor:
Yaping Yang, Ying Wang, Heran Deng, Cui Tan, Qian Li, Zhanghai He, Wei Wei, Enxiang Zhou, Qiang Liu, Jieqiong Liu
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-12 (2019)
Abstract Background Triple negative breast cancer (TNBC) is an aggressive and heterogeneous disease. Nomograms predicting outcomes of TNBC are needed for risk management. Methods Nomograms were based on an analysis of 296 non-metastatic TNBC patients
Externí odkaz:
https://doaj.org/article/ebe4b603fe3b4783a21333ca3b8ae427
Autor:
Jian Zhang, Fengxi Su, Tingting Hu, Shunrong Li, Heng Huang, Hui Huang, Luyuan Tan, Yanbo Chen, Heran Deng, Jiannan Wu, Liling Zhu, Kai Chen
Publikováno v:
BMJ Open, Vol 10, Iss 10 (2020)
Introduction The ideal treatment for idiopathic granulomatous mastitis (IGM) remains unclear. In a prospective, single-centre, pilot study, we reported that ductal lavage treatment for non-lactational mastitis patients had a 1-year clinical complete
Externí odkaz:
https://doaj.org/article/d0b0a5feb87f4875bcb090873cbb6824
Publikováno v:
Trials, Vol 18, Iss 1, Pp 1-6 (2017)
Abstract Background The response to neoadjuvant chemotherapy (NAC) varies by estrogen receptor (ER) and human epidermal growth factor receptor 2 (HER2) statuses, with responses being lower in ER-positive, HER2-negative tumors as compared with ER-nega
Externí odkaz:
https://doaj.org/article/9b540b8f9d134746903f020e811d2d6f
Publikováno v:
PLoS ONE, Vol 12, Iss 5, p e0176417 (2017)
Although subsequent breast cancer risk after primary lobular carcinoma in situ (LCIS) has been studied intensively, whether the risk of second breast cancer after first LCIS varies with hormone receptor (HR) status of primary tumor remains unclear.We
Externí odkaz:
https://doaj.org/article/853215698b1d406db8afa02491073c59
Autor:
Jiannan Wu, Shunrong Li, Weijuan Jia, Heran Deng, Kai Chen, Liling Zhu, Fengyan Yu, Fengxi Su
Publikováno v:
PLoS ONE, Vol 10, Iss 7, p e0133643 (2015)
Chemotherapy resistance remains an important problem in the breast cancer clinic. The ability to predict the patients who would respond to a distinct therapy would help to optimize tailored treatment options. miRNAs can mediate a number of genes in r
Externí odkaz:
https://doaj.org/article/529836d199db4ba4a53649b2578eb1a5